Yale Bulletin and Calendar

October 13, 2006|Volume 35, Number 6


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Proteins shown to have surprising
effects on autoimmune disease

Blocking the effect of individual immune system proteins that normally recognize viruses and bacteria produces surprisingly different effects on the severity of autoimmune diseases such as lupus, researchers at the School of Medicine report in the September issue of Immunity.

Drugs that target these proteins could be important therapies for autoimmunity.

Led by Dr. Mark Shlomchik, professor of laboratory medicine and immunobiology at Yale, the researchers examined the effect on disease when two similar Toll-like receptors (TLRs) were removed from mice in the study.

"These data showed that TLRs do indeed modulate overall autoimmune disease but not always in the expected way," says Shlomchik. "These are the first findings to show a definitive effect of TLR9 on anti-chromatin antibodies and are also the first to show the effect of TLR7 deficiency on autoantibodies and disease."

"We also found that mice without TLR9 lacked antibodies to DNA and that mice deficient in TLR7 lacked antibodies to RNA-associated antigens," notes Shlomchik. "When we examined the effect on disease, we were surprised to find that the two TLRs had very different effects. Mice deficient in TLR9 had worse disease, despite lacking anti-DNA antibodies, while TLR7-deficient mice had a milder form of disease."

Shlomchik says the study supports the idea that drugs that block TLR7 in particular could be promising as therapies, but he cautions against just blocking TLR9 -- a strategy, he notes, some biotech/pharmaceutical companies may have already begun using.

The study increases understanding of how the immune system and B cells in particular are activated by "self" antigens, putting direct focus on the TLR family of receptors. B cells make autoantibodies and may also stimulate the T lymphocytes that destroy tissues.

Shlomchik and his co-authors plan to explore why TLR7 and TLR9 had different effects on disease.

"We were very surprised because these two receptors are very similar to each other, generate signals in the same way and are expressed in the same cell types," he says. "We need to make mice deficient in both receptors to determine if TLR7 and TLR9 interact with each other and if blocking both inhibits disease even more effectively than blocking TLR7 alone."

Other authors on the study included Sean R. Christensen, Jonathan Shupe, Kevin Nickerson, Michael Kashgarian and Richard Flavell.

The study was funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Institute of Allergy and Infectious Diseases.

-- By Karen Peart


T H I SW E E K ' SS T O R I E S

Medical School receives $57.3 million NIH grant

Medical School receives $11.5 million to improve cancer diagnosis . . .

Museum technicians to show their own artworks at Open Studios

Student designs creative alternative to traditional construction fencing

MORE SCHOOL OF MEDICINE NEWS

Levin, Zedillo discuss the role of UNESCO at Paris event

'Women and Globalization' will be the topic of discussion . . .

Marketing executives and scholars to discuss latest trends

Australia's history and people are focus of film

Exhibit features paintings of England by Venetian artist 'Canaletto'

Lecture will examine the U.N. and 21st-century challenges

Lab talk

Play reading and talk will explore the romantic life of Benjamin Franklin

Tanner Lectures and related discussion to focus on humanities

'Crafting a Life' is the theme of this year's Law School reunions

Student research on early French songs culminates in . . .

Mutual interests

ALL gallery after-party celebrates artists in its newest exhibit and in CWOS

Campus Notes

Yale Books in Brief


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home